At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 62 enrolled
Drug / intervention
Occipital Nerve Blockdrug
Likely dose
Bupivacaine via occipital nerve block (specific dose not stated)AI-extracted
Key inclusion· 4
- ✓Pregnant patient with confirmed live intrauterine pregnancy
- ✓Acute headache complaint
- ✓Headache pain severity at least 4 on visual rating scale
- ✓Presenting to Maternal Evaluation Unit at UAB hospital
Key exclusion· 10
- ✕Systolic BP ≥140 or diastolic BP ≥90 with 1+ protein on urine dipstick (preeclampsia)
- ✕Systolic BP ≥160 or diastolic BP ≥105
- ✕Focal neurological symptoms
- ✕Altered level of consciousness or disorientation
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acute Headache Treatment in Pregnancy: Improvement in Pain Scores With Occipital Nerve Block vs PO Acetaminophen With Caffeine A Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Occipital Nerve Block for Headache and 2 related conditions. Completed, enrolled 62 participants across 1 site.
Detailed Summary
This is an open label randomized controlled trial evaluating response to bupivacaine occipital nerve block compared to Tylenol/Caffeine cocktail in treatment of pregnant patients seeking care of headache.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeadache, Pregnancy Related, Occipital Nerve Block
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedMay 2019
Enrollment StartFeb 2020
Primary CompletionDec 2022
TodayJul 2026
First PostedMay 15, 2019
Enrollment StartFeb 10, 2020
Primary CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 7.1 years ago
Interventions
Occipital Nerve Blockdrug
This is an open label randomized controlled trial evaluating response to bupivacaine occipital nerve block compared to Tylenol/Caffeine cocktail in treatment of pregnant patients seeking care of headache.